Rank | Gene Set | Z-score |
---|---|---|
1 | glomerulus development (GO:0032835) | 8.35071345 |
2 | skeletal muscle adaptation (GO:0043501) | 7.40022070 |
3 | mesenchymal-epithelial cell signaling (GO:0060638) | 6.13277308 |
4 | surfactant homeostasis (GO:0043129) | 6.13031048 |
5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.96707888 |
6 | drug transmembrane transport (GO:0006855) | 5.68066002 |
7 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 5.58907762 |
8 | excretion (GO:0007588) | 5.33287223 |
9 | camera-type eye morphogenesis (GO:0048593) | 5.31470720 |
10 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 5.23203743 |
11 | epithelial cell differentiation involved in kidney development (GO:0035850) | 5.17418788 |
12 | otic vesicle formation (GO:0030916) | 5.03467429 |
13 | urate metabolic process (GO:0046415) | 4.85595904 |
14 | radial glial cell differentiation (GO:0060019) | 4.85068020 |
15 | metanephric epithelium development (GO:0072207) | 4.76435382 |
16 | chemical homeostasis within a tissue (GO:0048875) | 4.72156671 |
17 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.70520162 |
18 | negative regulation of stress fiber assembly (GO:0051497) | 4.67058882 |
19 | lateral sprouting from an epithelium (GO:0060601) | 4.59110887 |
20 | muscle cell fate commitment (GO:0042693) | 4.53467389 |
21 | keratan sulfate catabolic process (GO:0042340) | 4.48260178 |
22 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 4.47766031 |
23 | phosphate ion transport (GO:0006817) | 4.46099396 |
24 | drug transport (GO:0015893) | 4.44168371 |
25 | positive regulation of male gonad development (GO:2000020) | 4.40173892 |
26 | negative regulation of Rho protein signal transduction (GO:0035024) | 4.38688005 |
27 | embryonic camera-type eye development (GO:0031076) | 4.36521403 |
28 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.28561082 |
29 | striated muscle hypertrophy (GO:0014897) | 4.16493443 |
30 | positive regulation of p38MAPK cascade (GO:1900745) | 4.10902847 |
31 | lysine metabolic process (GO:0006553) | 4.09796379 |
32 | lysine catabolic process (GO:0006554) | 4.09796379 |
33 | protein localization to cell surface (GO:0034394) | 4.01837859 |
34 | peripheral nervous system axon ensheathment (GO:0032292) | 4.00135410 |
35 | myelination in peripheral nervous system (GO:0022011) | 4.00135410 |
36 | endothelial cell chemotaxis (GO:0035767) | 3.96909652 |
37 | renal filtration (GO:0097205) | 3.96456153 |
38 | organic cation transport (GO:0015695) | 3.91869193 |
39 | response to mercury ion (GO:0046689) | 3.89279739 |
40 | muscle hypertrophy (GO:0014896) | 3.81879611 |
41 | metanephric tubule development (GO:0072170) | 3.77884102 |
42 | metanephric nephron tubule development (GO:0072234) | 3.77884102 |
43 | regulation of male gonad development (GO:2000018) | 3.77581819 |
44 | striated muscle adaptation (GO:0014888) | 3.77183562 |
45 | lung epithelium development (GO:0060428) | 3.74722524 |
46 | myoblast fusion (GO:0007520) | 3.74337728 |
47 | phosphate ion transmembrane transport (GO:0035435) | 3.73243890 |
48 | metanephric nephron epithelium development (GO:0072243) | 3.70240126 |
49 | coronary vasculature morphogenesis (GO:0060977) | 3.70001687 |
50 | renal absorption (GO:0070293) | 3.69711418 |
51 | regulation of glomerular filtration (GO:0003093) | 3.65254483 |
52 | lung vasculature development (GO:0060426) | 3.62624060 |
53 | cell adhesion mediated by integrin (GO:0033627) | 3.62391772 |
54 | kidney mesenchyme development (GO:0072074) | 3.61782256 |
55 | renal system process involved in regulation of blood volume (GO:0001977) | 3.56447997 |
56 | metanephric mesenchyme development (GO:0072075) | 3.56433481 |
57 | organ growth (GO:0035265) | 3.54983847 |
58 | myofibril assembly (GO:0030239) | 3.54166813 |
59 | cell migration involved in heart development (GO:0060973) | 3.52311232 |
60 | muscle filament sliding (GO:0030049) | 3.51342653 |
61 | actin-myosin filament sliding (GO:0033275) | 3.51342653 |
62 | regulation of axon guidance (GO:1902667) | 3.49122043 |
63 | quaternary ammonium group transport (GO:0015697) | 3.48958879 |
64 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.48712105 |
65 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.48165601 |
66 | genitalia morphogenesis (GO:0035112) | 3.46293133 |
67 | lymphangiogenesis (GO:0001946) | 3.45434488 |
68 | induction of positive chemotaxis (GO:0050930) | 3.45381513 |
69 | diaphragm development (GO:0060539) | 3.44048314 |
70 | negative regulation of metanephros development (GO:0072217) | 3.40516052 |
71 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.37600670 |
72 | gonadal mesoderm development (GO:0007506) | 3.37155103 |
73 | positive regulation of cell junction assembly (GO:1901890) | 3.37079149 |
74 | positive regulation of focal adhesion assembly (GO:0051894) | 3.37079149 |
75 | sex determination (GO:0007530) | 3.36501991 |
76 | activation of Rac GTPase activity (GO:0032863) | 3.35874283 |
77 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.33033413 |
78 | positive regulation of adherens junction organization (GO:1903393) | 3.30505676 |
79 | bicarbonate transport (GO:0015701) | 3.30099339 |
80 | regulation of p38MAPK cascade (GO:1900744) | 3.29624961 |
81 | negative regulation of axon guidance (GO:1902668) | 3.28999305 |
82 | venous blood vessel morphogenesis (GO:0048845) | 3.25150990 |
83 | angiotensin maturation (GO:0002003) | 3.23101472 |
84 | lymph vessel development (GO:0001945) | 3.21603813 |
85 | wound healing, spreading of epidermal cells (GO:0035313) | 3.21405558 |
86 | cardiac myofibril assembly (GO:0055003) | 3.20693180 |
87 | eye morphogenesis (GO:0048592) | 3.19931820 |
88 | drug catabolic process (GO:0042737) | 3.19875200 |
89 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.19509903 |
90 | exogenous drug catabolic process (GO:0042738) | 3.15554536 |
91 | positive regulation of digestive system process (GO:0060456) | 3.13949880 |
92 | regulation of hippo signaling (GO:0035330) | 3.12143385 |
93 | mesonephros development (GO:0001823) | 3.12097698 |
94 | vitamin D metabolic process (GO:0042359) | 3.08696592 |
95 | cardiac muscle cell proliferation (GO:0060038) | 3.08174107 |
96 | protein localization to endosome (GO:0036010) | 3.07854017 |
97 | actin-mediated cell contraction (GO:0070252) | 3.05726380 |
98 | lung secretory cell differentiation (GO:0061140) | 3.03726343 |
99 | phosphate ion homeostasis (GO:0055062) | 2.99586757 |
100 | trivalent inorganic anion homeostasis (GO:0072506) | 2.99586757 |
101 | apoptotic cell clearance (GO:0043277) | 2.99210644 |
102 | skeletal muscle organ development (GO:0060538) | 2.98511702 |
103 | nephron epithelium development (GO:0072009) | 2.97936774 |
104 | embryonic digestive tract morphogenesis (GO:0048557) | 2.96392905 |
105 | limb bud formation (GO:0060174) | 2.95975228 |
106 | sarcomere organization (GO:0045214) | 2.95010363 |
107 | positive regulation of catenin import into nucleus (GO:0035413) | 2.94552143 |
108 | basement membrane organization (GO:0071711) | 2.94102650 |
109 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.93500095 |
110 | glomerular filtration (GO:0003094) | 2.93151980 |
111 | * collagen metabolic process (GO:0032963) | 2.93038283 |
112 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.92205037 |
113 | hypotonic response (GO:0006971) | 2.92096317 |
114 | peptidyl-proline hydroxylation (GO:0019511) | 2.91408031 |
115 | pericardium development (GO:0060039) | 2.91308642 |
116 | * collagen catabolic process (GO:0030574) | 2.91300252 |
117 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.91205415 |
118 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.90284590 |
119 | protein heterotrimerization (GO:0070208) | 2.89817231 |
120 | actin filament-based movement (GO:0030048) | 2.89501068 |
121 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.89329290 |
122 | nephron tubule development (GO:0072080) | 2.89014309 |
123 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.88166765 |
124 | neuronal ion channel clustering (GO:0045161) | 2.87905304 |
125 | muscle adaptation (GO:0043500) | 2.87302507 |
126 | smooth muscle cell differentiation (GO:0051145) | 2.85474724 |
127 | cellular response to reactive nitrogen species (GO:1902170) | 2.85211205 |
128 | collagen fibril organization (GO:0030199) | 2.85070541 |
129 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.84868647 |
130 | protein hydroxylation (GO:0018126) | 2.82599887 |
131 | cornea development in camera-type eye (GO:0061303) | 2.82470822 |
132 | epithelial cell-cell adhesion (GO:0090136) | 2.81819759 |
133 | peptide catabolic process (GO:0043171) | 2.81641167 |
134 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.78990806 |
135 | glyoxylate metabolic process (GO:0046487) | 2.78064460 |
136 | amino-acid betaine transport (GO:0015838) | 2.77894873 |
137 | carnitine transport (GO:0015879) | 2.77894873 |
138 | cellular response to antibiotic (GO:0071236) | 2.77302181 |
139 | fibroblast migration (GO:0010761) | 2.77143773 |
140 | * multicellular organismal macromolecule metabolic process (GO:0044259) | 2.76751031 |
141 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.76243784 |
142 | renal system process (GO:0003014) | 2.75963616 |
143 | syncytium formation (GO:0006949) | 2.75791849 |
144 | actomyosin structure organization (GO:0031032) | 2.75554159 |
145 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.75122117 |
146 | cell differentiation involved in kidney development (GO:0061005) | 2.72995741 |
147 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.72757766 |
148 | tricarboxylic acid metabolic process (GO:0072350) | 2.70858596 |
149 | negative regulation of complement activation (GO:0045916) | 2.70551973 |
150 | homocysteine metabolic process (GO:0050667) | 2.69717421 |
151 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.69066585 |
152 | striated muscle cell proliferation (GO:0014855) | 2.68250332 |
153 | * multicellular organismal metabolic process (GO:0044236) | 2.67992581 |
154 | toxin transport (GO:1901998) | 2.67947475 |
155 | sodium-independent organic anion transport (GO:0043252) | 2.67684843 |
156 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.66598442 |
157 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.66294292 |
158 | * multicellular organismal catabolic process (GO:0044243) | 2.63823541 |
159 | regulation of alkaline phosphatase activity (GO:0010692) | 2.63695278 |
160 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.63059117 |
161 | endocytic recycling (GO:0032456) | 2.62421430 |
162 | short-chain fatty acid metabolic process (GO:0046459) | 2.61556849 |
163 | negative regulation of vascular permeability (GO:0043116) | 2.60636648 |
164 | cysteine metabolic process (GO:0006534) | 2.59960546 |
165 | renal tubule development (GO:0061326) | 2.59055998 |
166 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.58989671 |
167 | stress fiber assembly (GO:0043149) | 2.55636006 |
168 | regulation of mitochondrial depolarization (GO:0051900) | 2.55391163 |
169 | glucocorticoid biosynthetic process (GO:0006704) | 2.55293553 |
170 | white fat cell differentiation (GO:0050872) | 2.55225137 |
171 | polyol transport (GO:0015791) | 2.54369439 |
172 | non-canonical Wnt signaling pathway (GO:0035567) | 2.54296188 |
173 | thyroid gland development (GO:0030878) | 2.53495392 |
174 | plasma membrane repair (GO:0001778) | 2.53314792 |
175 | valine metabolic process (GO:0006573) | 2.52921870 |
176 | renal tubule morphogenesis (GO:0061333) | 2.52119260 |
177 | establishment of nucleus localization (GO:0040023) | 2.52046102 |
178 | endothelium development (GO:0003158) | 2.51325505 |
179 | mesenchymal cell differentiation (GO:0048762) | 2.51290208 |
180 | cellular response to vitamin D (GO:0071305) | 2.50921966 |
181 | regulation of relaxation of muscle (GO:1901077) | 2.50716401 |
182 | glomerular visceral epithelial cell development (GO:0072015) | 14.7914721 |
183 | glomerular epithelial cell development (GO:0072310) | 13.1754889 |
184 | * glomerular basement membrane development (GO:0032836) | 10.5422929 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.86987878 |
2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.75614812 |
3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.02956542 |
4 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.99396133 |
5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.78347359 |
6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.77068741 |
7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.72461695 |
8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.50096451 |
9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.33428260 |
10 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.29779883 |
11 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 2.19232523 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.10995002 |
13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.10747838 |
14 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.01338076 |
15 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.99893969 |
16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89859379 |
17 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.87157816 |
18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.87056007 |
19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86959623 |
20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.84878216 |
21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.82345544 |
22 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.78455038 |
23 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.77597829 |
24 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.77331032 |
25 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.74558116 |
26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.74289241 |
27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69206805 |
28 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67284534 |
29 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.64462904 |
30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.63832485 |
31 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63460823 |
32 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62154615 |
33 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60374385 |
34 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.59635492 |
35 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.55516624 |
36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54746396 |
37 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.54644444 |
38 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.54644444 |
39 | TP53_16413492_ChIP-PET_HCT116_Human | 1.52650769 |
40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51093107 |
41 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.48897362 |
42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.47424973 |
43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46822706 |
44 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.44168974 |
45 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.41188109 |
46 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40876765 |
47 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.39612612 |
48 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38622695 |
49 | CJUN_26792858_Chip-Seq_BT549_Human | 1.35905271 |
50 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.35028335 |
51 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.33858778 |
52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33377217 |
53 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.32639042 |
54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.29364342 |
55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.26293627 |
56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25930850 |
57 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.25159724 |
58 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25051800 |
59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24671392 |
60 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.24615921 |
61 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.24615921 |
62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24293853 |
63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21626963 |
64 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.19691772 |
65 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19622393 |
66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19036334 |
67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.17706366 |
68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15551742 |
69 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.14610583 |
70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13274269 |
71 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.12578044 |
72 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.09867141 |
73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09664745 |
74 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08877774 |
75 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08845263 |
76 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08633257 |
77 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.08100342 |
78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07988780 |
79 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06786885 |
80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06261598 |
81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05923258 |
82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04812724 |
83 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04119815 |
84 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03879513 |
85 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.03445538 |
86 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02845186 |
87 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.02436235 |
88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01925828 |
89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01707855 |
90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99880582 |
91 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99792099 |
92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99605873 |
93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99533880 |
94 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98511563 |
95 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98461816 |
96 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97979635 |
97 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.97207779 |
98 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96953336 |
99 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.95775409 |
100 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95303276 |
101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95296348 |
102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95241530 |
103 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95123545 |
104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94765781 |
105 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94117699 |
106 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92841872 |
107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92223412 |
108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91571184 |
109 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91519123 |
110 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91478215 |
111 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91263372 |
112 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90878743 |
113 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90133896 |
114 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.89582593 |
115 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89362374 |
116 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88134137 |
117 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87520301 |
118 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.86762059 |
119 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.86484478 |
120 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.86479983 |
121 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86340046 |
122 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86340046 |
123 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85910934 |
124 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85690514 |
125 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.85474815 |
126 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84756292 |
127 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84756292 |
128 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.84562863 |
129 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.84315819 |
130 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84110867 |
131 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.83834853 |
132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83751963 |
133 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.83737427 |
134 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.83726383 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005257_abnormal_intraocular_pressure | 4.77662497 |
2 | MP0004043_abnormal_pH_regulation | 4.29194187 |
3 | MP0004272_abnormal_basement_membrane | 4.09005275 |
4 | MP0001958_emphysema | 3.69779916 |
5 | MP0003195_calcinosis | 3.57391974 |
6 | MP0005360_urolithiasis | 3.42897549 |
7 | MP0009643_abnormal_urine_homeostasis | 3.29647947 |
8 | MP0003878_abnormal_ear_physiology | 3.27498468 |
9 | MP0005377_hearing/vestibular/ear_phenot | 3.27498468 |
10 | MP0005623_abnormal_meninges_morphology | 3.18826887 |
11 | MP0002138_abnormal_hepatobiliary_system | 2.97230765 |
12 | * MP0005332_abnormal_amino_acid | 2.97182446 |
13 | MP0001756_abnormal_urination | 2.96864802 |
14 | MP0010030_abnormal_orbit_morphology | 2.96634997 |
15 | MP0004084_abnormal_cardiac_muscle | 2.90828946 |
16 | MP0010368_abnormal_lymphatic_system | 2.88795552 |
17 | MP0002102_abnormal_ear_morphology | 2.86159809 |
18 | * MP0002136_abnormal_kidney_physiology | 2.85549906 |
19 | MP0001661_extended_life_span | 2.81485172 |
20 | MP0005248_abnormal_Harderian_gland | 2.73120524 |
21 | MP0001879_abnormal_lymphatic_vessel | 2.54973342 |
22 | MP0008995_early_reproductive_senescence | 2.44615322 |
23 | MP0001765_abnormal_ion_homeostasis | 2.42777590 |
24 | MP0004019_abnormal_vitamin_homeostasis | 2.40329903 |
25 | MP0000537_abnormal_urethra_morphology | 2.11142655 |
26 | MP0000230_abnormal_systemic_arterial | 1.99949193 |
27 | MP0004036_abnormal_muscle_relaxation | 1.96452169 |
28 | MP0005167_abnormal_blood-brain_barrier | 1.90933007 |
29 | MP0005503_abnormal_tendon_morphology | 1.87449164 |
30 | MP0003252_abnormal_bile_duct | 1.86717701 |
31 | MP0008961_abnormal_basal_metabolism | 1.83748569 |
32 | MP0000534_abnormal_ureter_morphology | 1.80945595 |
33 | MP0003646_muscle_fatigue | 1.78925302 |
34 | MP0009384_cardiac_valve_regurgitation | 1.77691667 |
35 | * MP0002135_abnormal_kidney_morphology | 1.76727315 |
36 | MP0002139_abnormal_hepatobiliary_system | 1.75962359 |
37 | MP0003300_gastrointestinal_ulcer | 1.73710918 |
38 | MP0002168_other_aberrant_phenotype | 1.63631990 |
39 | MP0003942_abnormal_urinary_system | 1.61697488 |
40 | MP0002877_abnormal_melanocyte_morpholog | 1.54378139 |
41 | MP0003283_abnormal_digestive_organ | 1.51576622 |
42 | MP0005636_abnormal_mineral_homeostasis | 1.50436791 |
43 | MP0005193_abnormal_anterior_eye | 1.44156492 |
44 | MP0004087_abnormal_muscle_fiber | 1.43966333 |
45 | MP0000749_muscle_degeneration | 1.42863068 |
46 | MP0000733_abnormal_muscle_development | 1.41583743 |
47 | MP0002295_abnormal_pulmonary_circulatio | 1.41368975 |
48 | MP0000579_abnormal_nail_morphology | 1.39615007 |
49 | MP0002332_abnormal_exercise_endurance | 1.35318413 |
50 | MP0002132_abnormal_respiratory_system | 1.35287516 |
51 | MP0002909_abnormal_adrenal_gland | 1.33923443 |
52 | MP0006138_congestive_heart_failure | 1.28639689 |
53 | MP0004145_abnormal_muscle_electrophysio | 1.28555155 |
54 | MP0004885_abnormal_endolymph | 1.24621814 |
55 | MP0000759_abnormal_skeletal_muscle | 1.24342370 |
56 | MP0008438_abnormal_cutaneous_collagen | 1.22205242 |
57 | MP0002009_preneoplasia | 1.22034061 |
58 | MP0009250_abnormal_appendicular_skeleto | 1.20328306 |
59 | MP0003941_abnormal_skin_development | 1.19825557 |
60 | MP0002269_muscular_atrophy | 1.16802088 |
61 | MP0003566_abnormal_cell_adhesion | 1.16316557 |
62 | MP0003115_abnormal_respiratory_system | 1.14884118 |
63 | MP0000678_abnormal_parathyroid_gland | 1.14523613 |
64 | MP0005369_muscle_phenotype | 1.11147624 |
65 | MP0000566_synostosis | 1.07728490 |
66 | MP0003045_fibrosis | 1.05015830 |
67 | MP0002896_abnormal_bone_mineralization | 1.04874220 |
68 | MP0003091_abnormal_cell_migration | 1.04618703 |
69 | MP0008004_abnormal_stomach_pH | 1.03443224 |
70 | MP0009780_abnormal_chondrocyte_physiolo | 0.99299631 |
71 | MP0003705_abnormal_hypodermis_morpholog | 0.99019215 |
72 | MP0004484_altered_response_of | 0.98751948 |
73 | MP0004233_abnormal_muscle_weight | 0.97509896 |
74 | MP0005058_abnormal_lysosome_morphology | 0.96462585 |
75 | MP0002106_abnormal_muscle_physiology | 0.95876700 |
76 | MP0010352_gastrointestinal_tract_polyps | 0.92948557 |
77 | MP0002128_abnormal_blood_circulation | 0.92834680 |
78 | MP0004742_abnormal_vestibular_system | 0.92796825 |
79 | MP0002928_abnormal_bile_duct | 0.91494065 |
80 | MP0008775_abnormal_heart_ventricle | 0.91185397 |
81 | MP0008875_abnormal_xenobiotic_pharmacok | 0.90303961 |
82 | MP0005165_increased_susceptibility_to | 0.88221181 |
83 | MP0005670_abnormal_white_adipose | 0.87044388 |
84 | MP0005508_abnormal_skeleton_morphology | 0.86767844 |
85 | MP0004130_abnormal_muscle_cell | 0.86242912 |
86 | MP0010386_abnormal_urinary_bladder | 0.84524562 |
87 | MP0000767_abnormal_smooth_muscle | 0.84095883 |
88 | MP0000747_muscle_weakness | 0.81257541 |
89 | MP0005595_abnormal_vascular_smooth | 0.80972300 |
90 | MP0001299_abnormal_eye_distance/ | 0.80044121 |
91 | MP0005666_abnormal_adipose_tissue | 0.79892839 |
92 | MP0003950_abnormal_plasma_membrane | 0.79796823 |
93 | MP0004782_abnormal_surfactant_physiolog | 0.78867740 |
94 | MP0005319_abnormal_enzyme/_coenzyme | 0.77759785 |
95 | MP0002133_abnormal_respiratory_system | 0.77284003 |
96 | MP0005388_respiratory_system_phenotype | 0.77284003 |
97 | MP0000639_abnormal_adrenal_gland | 0.77257393 |
98 | MP0001544_abnormal_cardiovascular_syste | 0.76992942 |
99 | MP0005385_cardiovascular_system_phenoty | 0.76992942 |
100 | MP0000751_myopathy | 0.76565382 |
101 | MP0005023_abnormal_wound_healing | 0.76178479 |
102 | MP0005451_abnormal_body_composition | 0.76014226 |
103 | MP0005275_abnormal_skin_tensile | 0.75598549 |
104 | MP0001784_abnormal_fluid_regulation | 0.74660396 |
105 | MP0000538_abnormal_urinary_bladder | 0.74131578 |
106 | MP0001502_abnormal_circadian_rhythm | 0.73965213 |
107 | MP0003279_aneurysm | 0.73711952 |
108 | MP0005647_abnormal_sex_gland | 0.72863118 |
109 | MP0001614_abnormal_blood_vessel | 0.72347713 |
110 | MP0000013_abnormal_adipose_tissue | 0.71457363 |
111 | MP0002972_abnormal_cardiac_muscle | 0.71403748 |
112 | MP0002998_abnormal_bone_remodeling | 0.70708387 |
113 | MP0000163_abnormal_cartilage_morphology | 0.70487283 |
114 | MP0003879_abnormal_hair_cell | 0.70090941 |
115 | MP0002108_abnormal_muscle_morphology | 0.69910202 |
116 | MP0000762_abnormal_tongue_morphology | 0.69835052 |
117 | MP0003191_abnormal_cellular_cholesterol | 0.69047650 |
118 | MP0002092_abnormal_eye_morphology | 0.68027967 |
119 | MP0002060_abnormal_skin_morphology | 0.67638433 |
120 | MP0002115_abnormal_skeleton_extremities | 0.67251070 |
121 | MP0005375_adipose_tissue_phenotype | 0.67166470 |
122 | MP0000343_altered_response_to | 0.66205725 |
123 | MP0004085_abnormal_heartbeat | 0.64904684 |
124 | MP0002127_abnormal_cardiovascular_syste | 0.64491449 |
125 | MP0002933_joint_inflammation | 0.63086624 |
126 | MP0005620_abnormal_muscle_contractility | 0.62274972 |
127 | MP0001270_distended_abdomen | 0.60788232 |
128 | MP0000613_abnormal_salivary_gland | 0.57817727 |
129 | MP0000003_abnormal_adipose_tissue | 0.57533166 |
130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.56897796 |
131 | MP0005197_abnormal_uvea_morphology | 0.56345631 |
132 | MP0003828_pulmonary_edema | 0.54805025 |
133 | MP0002925_abnormal_cardiovascular_devel | 0.54650568 |
134 | MP0010630_abnormal_cardiac_muscle | 0.54606364 |
135 | MP0002697_abnormal_eye_size | 0.54262029 |
136 | MP0001915_intracranial_hemorrhage | 0.54204782 |
137 | MP0004215_abnormal_myocardial_fiber | 0.53690747 |
138 | MP0003385_abnormal_body_wall | 0.53450037 |
139 | MP0003137_abnormal_impulse_conducting | 0.53153982 |
140 | MP0003943_abnormal_hepatobiliary_system | 0.52716420 |
141 | MP0009278_abnormal_bone_marrow | 0.52191990 |
142 | MP0001727_abnormal_embryo_implantation | 0.50955397 |
143 | MP0005330_cardiomyopathy | 0.50819386 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypokalemic alkalosis (HP:0001949) | 7.03646831 |
2 | Increased circulating renin level (HP:0000848) | 6.77262963 |
3 | Focal segmental glomerulosclerosis (HP:0000097) | 6.75611668 |
4 | Mesangial abnormality (HP:0001966) | 6.69945833 |
5 | Hyperactive renin-angiotensin system (HP:0000841) | 6.56075360 |
6 | Metabolic alkalosis (HP:0200114) | 6.00324549 |
7 | Abnormality of chloride homeostasis (HP:0011422) | 5.94775637 |
8 | Glomerulosclerosis (HP:0000096) | 5.81876171 |
9 | Hypomagnesemia (HP:0002917) | 5.80786495 |
10 | Polyuria (HP:0000103) | 5.36115643 |
11 | Abnormal urine output (HP:0012590) | 5.12839780 |
12 | Abnormality of renal excretion (HP:0011036) | 4.87300635 |
13 | Abnormality of magnesium homeostasis (HP:0004921) | 4.81440012 |
14 | Renal salt wasting (HP:0000127) | 4.73102743 |
15 | Gout (HP:0001997) | 4.72324979 |
16 | Aplasia involving bones of the extremities (HP:0009825) | 4.59508744 |
17 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.59508744 |
18 | Aplasia of the phalanges of the hand (HP:0009802) | 4.59508744 |
19 | Tetany (HP:0001281) | 4.58432691 |
20 | Polydipsia (HP:0001959) | 4.45521289 |
21 | Abnormal drinking behavior (HP:0030082) | 4.45521289 |
22 | Abnormality of renin-angiotensin system (HP:0000847) | 4.43588535 |
23 | Hyperaldosteronism (HP:0000859) | 4.41531260 |
24 | Hypoalbuminemia (HP:0003073) | 4.21133580 |
25 | Abnormal albumin level (HP:0012116) | 4.21133580 |
26 | Tubular atrophy (HP:0000092) | 4.20460443 |
27 | Exercise-induced myalgia (HP:0003738) | 3.96504745 |
28 | Alkalosis (HP:0001948) | 3.94771217 |
29 | Muscle fiber inclusion bodies (HP:0100299) | 3.80236106 |
30 | Metaphyseal cupping (HP:0003021) | 3.75200881 |
31 | Nemaline bodies (HP:0003798) | 3.73722163 |
32 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.67921619 |
33 | Premature rupture of membranes (HP:0001788) | 3.63500807 |
34 | Type 1 muscle fiber predominance (HP:0003803) | 3.60597902 |
35 | * Stage 5 chronic kidney disease (HP:0003774) | 3.58618794 |
36 | Tubulointerstitial fibrosis (HP:0005576) | 3.55846887 |
37 | Hypercalciuria (HP:0002150) | 3.54148159 |
38 | Hypokalemia (HP:0002900) | 3.48341263 |
39 | Protrusio acetabuli (HP:0003179) | 3.48340545 |
40 | Facial shape deformation (HP:0011334) | 3.42499827 |
41 | Potter facies (HP:0002009) | 3.42499827 |
42 | Round ear (HP:0100830) | 3.42027005 |
43 | Lymphangioma (HP:0100764) | 3.37313358 |
44 | Glomerulonephritis (HP:0000099) | 3.32393043 |
45 | Partial duplication of the phalanx of hand (HP:0009999) | 3.30902819 |
46 | Aortic dissection (HP:0002647) | 3.24254527 |
47 | Conical tooth (HP:0000698) | 3.20649895 |
48 | Increased purine levels (HP:0004368) | 3.19272241 |
49 | Hyperuricemia (HP:0002149) | 3.19272241 |
50 | Abnormality of incisor morphology (HP:0011063) | 3.17223419 |
51 | Partial duplication of thumb phalanx (HP:0009944) | 3.14758601 |
52 | Proximal tubulopathy (HP:0000114) | 3.11080666 |
53 | Vascular tortuosity (HP:0004948) | 3.10070968 |
54 | Arterial tortuosity (HP:0005116) | 3.07903634 |
55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.06668792 |
56 | Abnormality of potassium homeostasis (HP:0011042) | 3.05165043 |
57 | Absent phalangeal crease (HP:0006109) | 3.05133875 |
58 | Corneal dystrophy (HP:0001131) | 3.03675974 |
59 | Mitral stenosis (HP:0001718) | 2.98944847 |
60 | Nephrocalcinosis (HP:0000121) | 2.97843300 |
61 | Flat cornea (HP:0007720) | 2.86652647 |
62 | Recurrent corneal erosions (HP:0000495) | 2.82185369 |
63 | Alacrima (HP:0000522) | 2.82088917 |
64 | Aplasia of the musculature (HP:0100854) | 2.77473282 |
65 | Abnormality of the radial head (HP:0003995) | 2.74814672 |
66 | Abnormal finger flexion creases (HP:0006143) | 2.72363783 |
67 | Abnormality of purine metabolism (HP:0004352) | 2.72099602 |
68 | Abnormality of proline metabolism (HP:0010907) | 2.68763131 |
69 | Hydroxyprolinuria (HP:0003080) | 2.68763131 |
70 | Delayed epiphyseal ossification (HP:0002663) | 2.66648951 |
71 | Metaphyseal dysplasia (HP:0100255) | 2.66038905 |
72 | Decreased lacrimation (HP:0000633) | 2.57660490 |
73 | Hypophosphatemia (HP:0002148) | 2.56449534 |
74 | Vascular calcification (HP:0004934) | 2.55244215 |
75 | * Nephritis (HP:0000123) | 2.54895026 |
76 | Chondrocalcinosis (HP:0000934) | 2.51194859 |
77 | * Corneal erosion (HP:0200020) | 2.46326592 |
78 | Cardiovascular calcification (HP:0011915) | 2.45856975 |
79 | Visceral angiomatosis (HP:0100761) | 2.44318252 |
80 | Gonadal dysgenesis (HP:0000133) | 2.42857120 |
81 | Mixed hearing impairment (HP:0000410) | 2.42051877 |
82 | Interstitial pulmonary disease (HP:0006530) | 2.34996575 |
83 | Abnormality of Sharpey fibers (HP:0100685) | 2.34870276 |
84 | Hyperglycinuria (HP:0003108) | 2.34087507 |
85 | Hyporeflexia of lower limbs (HP:0002600) | 2.33039239 |
86 | Decreased circulating renin level (HP:0003351) | 2.32809038 |
87 | Soft skin (HP:0000977) | 2.29408690 |
88 | Increased connective tissue (HP:0009025) | 2.29106989 |
89 | Distal arthrogryposis (HP:0005684) | 2.27020748 |
90 | Bladder diverticulum (HP:0000015) | 2.24858654 |
91 | Hyperextensible skin (HP:0000974) | 2.23595524 |
92 | Hemangiomatosis (HP:0007461) | 2.23238484 |
93 | Shallow orbits (HP:0000586) | 2.23094661 |
94 | Tubulointerstitial abnormality (HP:0001969) | 2.22938282 |
95 | Atrophic scars (HP:0001075) | 2.21815724 |
96 | Abnormality of sodium homeostasis (HP:0010931) | 2.19093042 |
97 | * Proteinuria (HP:0000093) | 2.16830146 |
98 | Fragile skin (HP:0001030) | 2.16703190 |
99 | Hypoplasia of the iris (HP:0007676) | 2.16608815 |
100 | Wormian bones (HP:0002645) | 2.16331061 |
101 | Ankle contracture (HP:0006466) | 2.14763546 |
102 | Nonprogressive disorder (HP:0003680) | 2.14666670 |
103 | Generalized aminoaciduria (HP:0002909) | 2.14521195 |
104 | Exercise-induced muscle cramps (HP:0003710) | 2.13706412 |
105 | Asymmetric septal hypertrophy (HP:0001670) | 2.12792143 |
106 | Adrenal overactivity (HP:0002717) | 2.09386050 |
107 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.09033894 |
108 | Abnormal tarsal ossification (HP:0008369) | 2.07881584 |
109 | Broad hallux (HP:0010055) | 2.06600050 |
110 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.06269037 |
111 | Renal tubular acidosis (HP:0001947) | 2.06073293 |
112 | Thin bony cortex (HP:0002753) | 2.05710905 |
113 | Polycythemia (HP:0001901) | 2.04581388 |
114 | Hematochezia (HP:0002573) | 2.04507844 |
115 | Hyponatremia (HP:0002902) | 2.03539873 |
116 | Camptodactyly of toe (HP:0001836) | 2.01481208 |
117 | Muscle fiber splitting (HP:0003555) | 1.98845037 |
118 | Neonatal respiratory distress (HP:0002643) | 1.98485528 |
119 | Nasolacrimal duct obstruction (HP:0000579) | 1.96232132 |
120 | Hyperkalemia (HP:0002153) | 1.95812813 |
121 | Ketoacidosis (HP:0001993) | 1.95765162 |
122 | Hypoproteinemia (HP:0003075) | 1.94703808 |
123 | Abnormality of the salivary glands (HP:0010286) | 1.94610201 |
124 | EMG: myopathic abnormalities (HP:0003458) | 1.93583153 |
125 | Cubitus valgus (HP:0002967) | 1.93210109 |
126 | Hip contracture (HP:0003273) | 1.92654929 |
127 | * Nephrotic syndrome (HP:0000100) | 1.92519325 |
128 | Calf muscle hypertrophy (HP:0008981) | 1.92276428 |
129 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.92194044 |
130 | Osteolytic defects of the hand bones (HP:0009699) | 1.92194044 |
131 | Bicornuate uterus (HP:0000813) | 1.92179130 |
132 | Myoglobinuria (HP:0002913) | 1.92140163 |
133 | Abnormality of the calf musculature (HP:0001430) | 1.88590181 |
134 | Aortic aneurysm (HP:0004942) | 1.87922248 |
135 | Male infertility (HP:0003251) | 1.86376585 |
136 | Vertebral compression fractures (HP:0002953) | 1.84533350 |
137 | Abnormal urine phosphate concentration (HP:0012599) | 1.84129620 |
138 | Subaortic stenosis (HP:0001682) | 1.83994057 |
139 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.83994057 |
140 | Difficulty running (HP:0009046) | 1.82976734 |
141 | Abnormality of molar (HP:0011077) | 1.81773419 |
142 | Abnormality of molar morphology (HP:0011070) | 1.81773419 |
143 | Dislocated radial head (HP:0003083) | 1.81036291 |
144 | Limited elbow extension (HP:0001377) | 1.80758221 |
145 | Ulnar bowing (HP:0003031) | 1.80243653 |
146 | Nephrolithiasis (HP:0000787) | 1.79947461 |
147 | Hand muscle atrophy (HP:0009130) | 1.79102596 |
148 | Increased variability in muscle fiber diameter (HP:0003557) | 1.78425543 |
149 | Striae distensae (HP:0001065) | 1.78405631 |
150 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.78373922 |
151 | Increased corneal curvature (HP:0100692) | 1.78328654 |
152 | Keratoconus (HP:0000563) | 1.78328654 |
153 | Dehydration (HP:0001944) | 1.77222762 |
154 | Abnormality of glycine metabolism (HP:0010895) | 1.76400143 |
155 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.76400143 |
156 | Taurodontia (HP:0000679) | 1.75202389 |
157 | Abnormality of permanent molar morphology (HP:0011071) | 1.75202389 |
158 | Rapidly progressive (HP:0003678) | 1.75099073 |
159 | Hyperphosphaturia (HP:0003109) | 1.75074868 |
160 | Testicular neoplasm (HP:0010788) | 1.73766710 |
161 | Abnormality of nucleobase metabolism (HP:0010932) | 1.72283830 |
162 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.72008313 |
163 | Polar cataract (HP:0010696) | 1.69937978 |
164 | Rectal prolapse (HP:0002035) | 1.69919511 |
165 | Generalized muscle weakness (HP:0003324) | 1.68624988 |
166 | Glycosuria (HP:0003076) | 1.67500929 |
167 | Abnormality of urine glucose concentration (HP:0011016) | 1.67500929 |
168 | Abnormality of the fingertips (HP:0001211) | 1.66497648 |
169 | Persistence of primary teeth (HP:0006335) | 1.66371235 |
170 | Germ cell neoplasia (HP:0100728) | 1.66218410 |
171 | Broad metatarsal (HP:0001783) | 1.64799830 |
172 | * Hematuria (HP:0000790) | 1.64248377 |
173 | Cerebral aneurysm (HP:0004944) | 1.64150109 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK4 | 7.31942905 |
2 | WNK3 | 6.04381283 |
3 | OXSR1 | 5.77813154 |
4 | OBSCN | 4.41229464 |
5 | STK39 | 3.98572515 |
6 | TIE1 | 3.33196464 |
7 | EPHB2 | 2.91871174 |
8 | TGFBR2 | 2.71239916 |
9 | MYLK | 2.59054517 |
10 | TRPM7 | 2.32647363 |
11 | PAK4 | 2.27884913 |
12 | PHKG1 | 1.99274098 |
13 | PHKG2 | 1.99274098 |
14 | STK38L | 1.89728788 |
15 | MOS | 1.77620108 |
16 | LATS1 | 1.77454325 |
17 | TRIB3 | 1.76983811 |
18 | WNK1 | 1.76071041 |
19 | MAPK7 | 1.73972334 |
20 | EPHA3 | 1.73238395 |
21 | EPHB1 | 1.70245181 |
22 | EEF2K | 1.66967245 |
23 | AKT3 | 1.58065921 |
24 | RIPK1 | 1.53684830 |
25 | MAP3K13 | 1.43793073 |
26 | PDGFRA | 1.41419985 |
27 | PIK3CG | 1.40205750 |
28 | PDK4 | 1.38612414 |
29 | PDK3 | 1.38612414 |
30 | MELK | 1.38533838 |
31 | MAPK12 | 1.35277395 |
32 | KDR | 1.35069750 |
33 | PTK6 | 1.31023994 |
34 | PDK2 | 1.30927475 |
35 | MUSK | 1.29978402 |
36 | FGFR4 | 1.20621587 |
37 | MST4 | 1.19166688 |
38 | MAPKAPK5 | 1.19161528 |
39 | NLK | 1.18781329 |
40 | SGK494 | 1.12806183 |
41 | SGK223 | 1.12806183 |
42 | LRRK2 | 1.07026012 |
43 | TYRO3 | 1.06568835 |
44 | FER | 1.04699390 |
45 | TGFBR1 | 1.04070280 |
46 | CDK12 | 0.99178036 |
47 | RPS6KC1 | 0.98496193 |
48 | RPS6KL1 | 0.98496193 |
49 | BCKDK | 0.93632046 |
50 | SGK3 | 0.90417794 |
51 | MAP3K7 | 0.90192399 |
52 | RPS6KA2 | 0.89988291 |
53 | GSK3A | 0.89388906 |
54 | PRKD3 | 0.87919158 |
55 | CDC42BPA | 0.86533026 |
56 | MAP3K14 | 0.86161782 |
57 | RPS6KA6 | 0.84280661 |
58 | SGK2 | 0.83683394 |
59 | TTN | 0.83368461 |
60 | MARK2 | 0.81526667 |
61 | ERN1 | 0.81088889 |
62 | RET | 0.80461634 |
63 | MAP3K6 | 0.78616526 |
64 | CCNB1 | 0.78042951 |
65 | PTK2 | 0.77285861 |
66 | TBK1 | 0.76767839 |
67 | PTK2B | 0.75265859 |
68 | ROCK1 | 0.75220824 |
69 | GRK5 | 0.73584977 |
70 | NME1 | 0.73135169 |
71 | PAK3 | 0.72986448 |
72 | MAPK11 | 0.72903943 |
73 | MAPK15 | 0.72828922 |
74 | MST1R | 0.72812900 |
75 | NTRK1 | 0.72607603 |
76 | FRK | 0.70772652 |
77 | STK38 | 0.68145904 |
78 | PAK2 | 0.66906153 |
79 | TYK2 | 0.66736852 |
80 | MAP4K2 | 0.63128949 |
81 | MAPKAPK3 | 0.62680489 |
82 | STK3 | 0.61492486 |
83 | PRKD2 | 0.61467528 |
84 | STK10 | 0.60905089 |
85 | PDGFRB | 0.60774699 |
86 | FGFR2 | 0.60588041 |
87 | CAMK1G | 0.59953518 |
88 | PRKCH | 0.58822882 |
89 | MAP3K3 | 0.56867574 |
90 | BMX | 0.53018342 |
91 | DAPK2 | 0.52919844 |
92 | MET | 0.52321401 |
93 | MTOR | 0.49816524 |
94 | ICK | 0.49816211 |
95 | DMPK | 0.49402317 |
96 | SCYL2 | 0.49057714 |
97 | LMTK2 | 0.48127618 |
98 | NEK6 | 0.47744470 |
99 | MAPK4 | 0.47057722 |
100 | IRAK1 | 0.44823171 |
101 | GRK7 | 0.44574331 |
102 | PDPK1 | 0.43763994 |
103 | SIK1 | 0.41173274 |
104 | MAP2K6 | 0.40023505 |
105 | EIF2AK2 | 0.39686996 |
106 | CAMK1D | 0.39489885 |
107 | SMG1 | 0.39251655 |
108 | NEK9 | 0.38840699 |
109 | MAP3K9 | 0.38307301 |
110 | PRPF4B | 0.37972355 |
111 | GRK1 | 0.37409014 |
112 | PRKD1 | 0.35741032 |
113 | MAP2K2 | 0.35574571 |
114 | CSK | 0.33228027 |
115 | SGK1 | 0.32458221 |
116 | LATS2 | 0.32355917 |
117 | MAPK3 | 0.31915159 |
118 | NEK1 | 0.31678695 |
119 | TLK1 | 0.30688764 |
120 | CAMK2B | 0.30478164 |
121 | FGFR3 | 0.30439812 |
122 | MAP2K1 | 0.30285967 |
123 | JAK1 | 0.29697744 |
124 | ABL2 | 0.29280673 |
125 | EGFR | 0.28218117 |
126 | FGFR1 | 0.25241378 |
127 | PRKAA1 | 0.25164906 |
128 | PRKAA2 | 0.23939964 |
129 | PKN2 | 0.23706315 |
130 | SRC | 0.23438396 |
131 | MAP3K2 | 0.23388460 |
132 | PRKCE | 0.23188055 |
133 | ABL1 | 0.21959070 |
134 | KIT | 0.20490381 |
135 | DYRK1B | 0.20056415 |
136 | ZAP70 | 0.19847149 |
137 | JAK2 | 0.19831288 |
138 | AKT2 | 0.18890586 |
139 | PRKACG | 0.18310361 |
140 | PRKACB | 0.18059286 |
141 | MAP2K3 | 0.17088974 |
142 | DDR2 | 0.16495768 |
143 | CHUK | 0.16001102 |
144 | PINK1 | 0.15913367 |
145 | PDK1 | 0.15566692 |
146 | IGF1R | 0.14679911 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.03538649 |
2 | Circadian rhythm_Homo sapiens_hsa04710 | 2.85507044 |
3 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 2.79581912 |
4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.50079980 |
5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.44859994 |
6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.38075679 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37818271 |
8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.35862719 |
9 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 2.32520488 |
10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.30386056 |
11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.29940916 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13662582 |
13 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.05327327 |
14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.04374479 |
15 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.95670356 |
16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81952822 |
17 | Lysine degradation_Homo sapiens_hsa00310 | 1.80885445 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76759868 |
19 | * Focal adhesion_Homo sapiens_hsa04510 | 1.75662216 |
20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.70772522 |
21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70494472 |
22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.65420509 |
23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.62261088 |
24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.61128622 |
25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.57589728 |
26 | Mineral absorption_Homo sapiens_hsa04978 | 1.56676391 |
27 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.56545493 |
28 | Bile secretion_Homo sapiens_hsa04976 | 1.55415456 |
29 | * Small cell lung cancer_Homo sapiens_hsa05222 | 1.49057443 |
30 | Melanoma_Homo sapiens_hsa05218 | 1.43519664 |
31 | Peroxisome_Homo sapiens_hsa04146 | 1.36826451 |
32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.36796727 |
33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.35938070 |
34 | * Amoebiasis_Homo sapiens_hsa05146 | 1.33556589 |
35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.27394027 |
36 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.20418224 |
37 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.19778084 |
38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15963406 |
39 | Axon guidance_Homo sapiens_hsa04360 | 1.15846746 |
40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15054316 |
41 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09216079 |
42 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.05120836 |
43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.01140553 |
44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.00678664 |
45 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00052537 |
46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99917034 |
47 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98082269 |
48 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.97359499 |
49 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.94782404 |
50 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94461235 |
51 | Tight junction_Homo sapiens_hsa04530 | 0.93428053 |
52 | Adherens junction_Homo sapiens_hsa04520 | 0.93232382 |
53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91410687 |
54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90997795 |
55 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89834820 |
56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85754474 |
57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85408139 |
58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85131234 |
59 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.84282971 |
60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83595423 |
61 | Lysosome_Homo sapiens_hsa04142 | 0.82768858 |
62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81872754 |
63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.81004658 |
64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.79970422 |
65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79501153 |
66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74939077 |
67 | Bladder cancer_Homo sapiens_hsa05219 | 0.74552640 |
68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72940785 |
69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72771939 |
70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71204866 |
71 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.70618749 |
72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69875231 |
73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69780010 |
74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69427595 |
75 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.68136865 |
76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67417146 |
77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67366123 |
78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66593527 |
79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66265452 |
80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64712786 |
81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63870124 |
82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63644698 |
83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63572764 |
84 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63345993 |
85 | Renin secretion_Homo sapiens_hsa04924 | 0.62712398 |
86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62350163 |
87 | Prostate cancer_Homo sapiens_hsa05215 | 0.60996517 |
88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60893713 |
89 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60772125 |
90 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60335105 |
91 | Insulin resistance_Homo sapiens_hsa04931 | 0.60006153 |
92 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58589078 |
93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58275796 |
94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56759410 |
95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55148671 |
96 | ABC transporters_Homo sapiens_hsa02010 | 0.54253746 |
97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53293246 |
98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52763428 |
99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51732050 |
100 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51406338 |
101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51377767 |
102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50884310 |
103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49565910 |
104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47766703 |
105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47545262 |
106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.47422755 |
107 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47022073 |
108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46976406 |
109 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46762970 |
110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46657516 |
111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46512862 |
112 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46326191 |
113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45969409 |
114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45799385 |
115 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.45656212 |
116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45410840 |
117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45387732 |
118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45275708 |
119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45011897 |
120 | Salivary secretion_Homo sapiens_hsa04970 | 0.44563512 |
121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44198667 |
122 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43780403 |
123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43648698 |
124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43636763 |
125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43564580 |
126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43320747 |
127 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43015773 |
128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42586966 |
129 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42544438 |
130 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41498602 |
131 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41415767 |
132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40496865 |
133 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.40442940 |
134 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39940714 |
135 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.39567552 |
136 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38022742 |
137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37802120 |
138 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37471036 |
139 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37448232 |
140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36968319 |
141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32416531 |